Revised statement is available on the SSC website here: http://www.survivingsepsis.org/Guidelines/Pages/default.aspx
Craig Coopersmith, MD, FACS, FCCM Professor of Surgery Director, 5E Surgical Intensive Care Unit Associate Director, Emory Critical Care Center Vice Chair for Research, Department of Surgery Emory University School of Medicine Atlanta, GA [email protected] Phone: (404) 727-4273 Fax: (404) 727-3660 President, Society of Critical Care Medicine -----Original Message----- From: Sepsisgroups [mailto:[email protected]] On Behalf Of [email protected] Sent: Thursday, March 26, 2015 9:27 AM To: [email protected] Subject: [Sepsis Groups] ProMISE study So the last of the 3 studies designed to test EGDT has been published. (ProMISE). This study along with the ARISE, and ProCESS have concluded that EGDT has no mortality benefit over usual or standard care. Does anyone know if Surviving Sepsis Campaign is going to put out a statement or are there going to be any changes to the guidelines?? I appreciate your input. Chelsea Bibelhauser RN, BSN Sepsis Coordinator Clark Memorial Hospital 1220 Missouri Ave Jeffersonville, IN 47130 812-283-2880 7 minutes online can save your life! Log onto www.clarkmemorial.org and click on HEARTaware. This information is intended only for the use of the individual or entity named above. The authorized recipient of this information is prohibited from disclosing this information to any other party unless required to do so by law or regulation. If you are not the intended recipient, you are hereby notified that any disclosure, copying, distribution, or action taken based on the contents of these documents is strictly prohibited by law. If you have received this message in error, please notify the Clark Memorial Hospital Privacy Officer at 812.283.2626. _______________________________________________ Sepsisgroups mailing list [email protected] http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org ________________________________ This e-mail message (including any attachments) is for the sole use of the intended recipient(s) and may contain confidential and privileged information. If the reader of this message is not the intended recipient, you are hereby notified that any dissemination, distribution or copying of this message (including any attachments) is strictly prohibited. If you have received this message in error, please contact the sender by reply e-mail message and destroy all copies of the original message (including attachments). _______________________________________________ Sepsisgroups mailing list [email protected] http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org
